{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:25:13Z","timestamp":1777983913528,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41005-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:19:57Z","timestamp":1771625997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based prediction of primary aldosteronism subtype using comprehensive clinical features"],"prefix":"10.1038","volume":"16","author":[{"given":"Yosuke","family":"Mizutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"41005_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young, W. F. Primary aldosteronism: Renaissance of a syndrome. Clin. Endocrinol. (Oxford) 66, 607\u2013618 (2007).","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"41005_CR2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone, S. et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69, 1811\u20131820 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"41005_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno, Y., Nagahama Study \/ JPAS Study Group. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71, 530\u2013537 (2018).","journal-title":"Hypertension"},{"key":"41005_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: case detection, diagnosis, and treatment. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR5","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","volume":"57","author":"O Vonend","year":"2011","unstructured":"Vonend, O. et al. Adrenal venous sampling: evaluation of the German Conn\u2019s registry. Hypertension 57, 990\u2013995 (2011).","journal-title":"Hypertension"},{"key":"41005_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/HYPERTENSIONAHA.115.06305","volume":"67","author":"S Monticone","year":"2016","unstructured":"Monticone, S. et al. Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism. Hypertension 67, 146\u2013152 (2016).","journal-title":"Hypertension"},{"key":"41005_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11307-024-01976-0","volume":"27","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. 68Ga-pentixafor PET\/CT is a supplementary method for primary aldosteronism subtyping compared with adrenal vein sampling. Mol. Imag. Biol. 27, 142\u2013150 (2025).","journal-title":"Mol. Imag. Biol."},{"key":"41005_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism. J. Clin. Endocrinol. Metab. 109, 171\u2013184 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR9","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/biomedicines11071934","volume":"11","author":"M Araujo-Castro","year":"2023","unstructured":"Araujo-Castro, M. et al. Diagnostic accuracy of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for the subtyping of primary aldosteronism. Biomedicines 11, 1934 (2023).","journal-title":"Biomedicines"},{"key":"41005_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-62703-748-8_7","volume":"1107","author":"Y Ba\u015ftanlar","year":"2014","unstructured":"Ba\u015ftanlar, Y. & \u00d6zuysal, M. Introduction to machine learning. Methods Mol. Biol. 1107, 105\u2013128 (2014).","journal-title":"Methods Mol. Biol."},{"key":"41005_CR11","first-page":"59","volume":"2","author":"JA Cruz","year":"2007","unstructured":"Cruz, J. A. & Wishart, D. S. Applications of machine learning in cancer prediction and prognosis. Cancer Inform. 2, 59\u201377 (2007).","journal-title":"Cancer Inform."},{"key":"41005_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ajh\/hpab195","volume":"35","author":"D Sam","year":"2022","unstructured":"Sam, D. et al. External validation of clinical prediction models in unilateral primary aldosteronism. Am. J. Hypertens. 35, 365\u2013373 (2022).","journal-title":"Am. J. Hypertens."},{"key":"41005_CR13","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1210\/jc.2012-1917","volume":"97","author":"EM K\u00fcpers","year":"2012","unstructured":"K\u00fcpers, E. M. et al. A clinical prediction score to diagnose unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 97, 3530\u20133537 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/HJH.0000000000001488","volume":"35","author":"Z Ying","year":"2017","unstructured":"Ying, Z. et al. Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score. J. Hypertens. 35, 2486\u20132492 (2017).","journal-title":"J. Hypertens."},{"key":"41005_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s12020-015-0615-9","volume":"50","author":"K Nanba","year":"2015","unstructured":"Nanba, K. et al. Shortened saline infusion test for subtype prediction in primary aldosteronism. Endocrine 50, 802\u2013806 (2015).","journal-title":"Endocrine"},{"key":"41005_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"Rossi, G. P. et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50, 424\u2013431 (2007).","journal-title":"Hypertension"},{"key":"41005_CR17","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1210\/jc.2011-0573","volume":"96","author":"T Sonoyama","year":"2011","unstructured":"Sonoyama, T. et al. Significance of adrenocorticotropin stimulation test in the diagnosis of aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 96, 2771\u20132778 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","volume":"62","author":"G Eisenhofer","year":"2016","unstructured":"Eisenhofer, G. et al. Mass spectrometry\u2013based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin. Chem. 62, 514\u2013524 (2016).","journal-title":"Clin. Chem."},{"key":"41005_CR19","doi-asserted-by":"publisher","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","volume":"3","author":"G Eisenhofer","year":"2020","unstructured":"Eisenhofer, G. et al. Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism. JAMA Netw. Open 3, e2016209 (2020).","journal-title":"JAMA Netw. Open"},{"key":"41005_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2009","unstructured":"Nishikawa, T. et al. Guidelines for the diagnosis and treatment of primary aldosteronism \u2014 The Japan Endocrine Society 2009. Endocr. J. 58, 711\u2013721 (2009).","journal-title":"Endocr. J."},{"key":"41005_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young Jr","year":"2004","unstructured":"Young, W. F. Jr. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227\u20131235 (2004).","journal-title":"Surgery"},{"key":"41005_CR22","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"41005_CR23","first-page":"281","volume":"13","author":"J Bergstra","year":"2012","unstructured":"Bergstra, J. & Bengio, Y. Random search for hyper-parameter optimization. J. Mach. Learn. Res. 13, 281\u2013305 (2012).","journal-title":"J. Mach. Learn. Res."},{"key":"41005_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cen.13278","volume":"86","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi, H. et al. Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling. Clin. Endocrinol. (Oxford) 86, 467\u2013472 (2017).","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"41005_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/jhh.2014.20","volume":"28","author":"K Nanba","year":"2014","unstructured":"Nanba, K. et al. A subtype prediction score for primary aldosteronism. J. Hum. Hypertens. 28, 716\u2013720 (2014).","journal-title":"J. Hum. Hypertens."},{"key":"41005_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ijms18040848","volume":"18","author":"F Buffolo","year":"2017","unstructured":"Buffolo, F. et al. Subtype diagnosis of primary aldosteronism: Is adrenal vein sampling always necessary?. Int. J. Mol. Sci. 18, 848 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"41005_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1507\/endocrj.EJ20-0395","volume":"68","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Computed tomography combined with confirmatory tests for the diagnosis of aldosterone-producing adenoma. Endocr. J. 68, 299\u2013306 (2021).","journal-title":"Endocr. J."},{"key":"41005_CR28","doi-asserted-by":"publisher","first-page":"634879","DOI":"10.3389\/fonc.2021.634879","volume":"11","author":"K He","year":"2021","unstructured":"He, K. et al. A clinical radiomic nomogram based on unenhanced computed tomography for predicting the risk of aldosterone-producing adenoma. Front. Oncol. 11, 634879 (2021).","journal-title":"Front. Oncol."},{"key":"41005_CR29","doi-asserted-by":"publisher","first-page":"e3706","DOI":"10.1210\/clinem\/dgaa379","volume":"105","author":"J Burrello","year":"2020","unstructured":"Burrello, J. et al. Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 105, e3706\u2013e3717 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR30","doi-asserted-by":"publisher","first-page":"9140","DOI":"10.1038\/s41598-021-88712-8","volume":"11","author":"H Kaneko","year":"2021","unstructured":"Kaneko, H. et al. Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test. Sci. Rep. 11, 9140 (2021).","journal-title":"Sci. Rep."},{"key":"41005_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40292-022-00523-8","volume":"29","author":"S Tamaru","year":"2022","unstructured":"Tamaru, S. et al. Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling. High Blood Press. Cardiovasc. Prev. 29, 375\u2013383 (2022).","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"41005_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3904\/kjim.2013.28.6.739","volume":"28","author":"JM Byun","year":"2013","unstructured":"Byun, J. M. et al. A case of primary aldosteronism presenting as non\u2013ST elevation myocardial infarction. Korean J. Intern. Med. 28, 739\u2013742 (2013).","journal-title":"Korean J. Intern. Med."},{"key":"41005_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12902-020-00601-9","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Is primary aldosteronism a potential risk factor for aortic dissection? A case report and literature review. BMC Endocr. Disord. 20, 115 (2020).","journal-title":"BMC Endocr. Disord."},{"key":"41005_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.radcr.2019.04.011","volume":"14","author":"C Fava","year":"2019","unstructured":"Fava, C. et al. Unusual presentation of primary aldosteronism with advanced target organ damage: A case report. Radiol. Case Rep. 14, 814\u2013818 (2019).","journal-title":"Radiol. Case Rep."},{"key":"41005_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/jhh.2016.61","volume":"31","author":"K Kamemura","year":"2017","unstructured":"Kamemura, K. et al. Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism. J. Hum. Hypertens. 31, 195\u2013199 (2017).","journal-title":"J. Hum. Hypertens."},{"key":"41005_CR36","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","volume":"36","author":"H Kobayashi","year":"2018","unstructured":"Kobayashi, H. et al. Development and validation of subtype prediction scores for the workup of primary aldosteronism. J. Hypertens. 36, 2269\u20132276 (2018).","journal-title":"J. Hypertens."},{"key":"41005_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4158\/EP15982.OR","volume":"22","author":"T Kocjan","year":"2016","unstructured":"Kocjan, T. et al. A new clinical prediction criterion accurately determines a subset of patients with bilateral primary aldosteronism before adrenal venous sampling. Endocr. Pract. 22, 587\u2013594 (2016).","journal-title":"Endocr. Pract."},{"key":"41005_CR38","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1210\/jc.2017-01774","volume":"103","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi, H. et al. Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 103, 900\u2013908 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","volume":"60","author":"GP Rossi","year":"2012","unstructured":"Rossi, G. P. et al. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Hypertension 60, 431\u2013436 (2012).","journal-title":"Hypertension"},{"key":"41005_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.amjhyper.2004.09.016","volume":"18","author":"J Kato","year":"2005","unstructured":"Kato, J. et al. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am. J. Hypertens. 18, 354\u2013357 (2005).","journal-title":"Am. J. Hypertens."},{"key":"41005_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/08037050601037760","volume":"15","author":"P Jakubik","year":"2006","unstructured":"Jakubik, P. et al. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press. 15, 302\u2013307 (2006).","journal-title":"Blood Press."},{"key":"41005_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2017-01530","volume":"103","author":"M Xiao","year":"2018","unstructured":"Xiao, M. et al. Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 103, 853\u2013860 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1507\/endocrj.EJ16-0297","volume":"64","author":"A Moriya","year":"2017","unstructured":"Moriya, A. et al. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism. Endocr. J. 64, 65\u201373 (2017).","journal-title":"Endocr. J."},{"key":"41005_CR44","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2018-00866","volume":"103","author":"Y Ohno","year":"2018","unstructured":"Ohno, Y., JPAS Study Group. Obesity as a key factor underlying idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 103, 4456\u20134464 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR45","doi-asserted-by":"publisher","first-page":"e038489","DOI":"10.1136\/bmjopen-2020-038489","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: Systematic review and meta-analysis. BMJ Open 10, e038489 (2020).","journal-title":"BMJ Open"},{"key":"41005_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"Mulatero, P. et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtype. J. Clin. Endocrinol. Metab. 97, 881\u2013889 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"41005_CR47","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","volume":"65","author":"F Satoh","year":"2015","unstructured":"Satoh, F. et al. Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral disease in patients with primary aldosteronism. Hypertension 65, 1096\u20131102 (2015).","journal-title":"Hypertension"},{"key":"41005_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/EJE-17-0563","volume":"178","author":"JWM Lenders","year":"2018","unstructured":"Lenders, J. W. M. et al. Diagnosis of endocrine disease: 18-oxocortisol and 18-hydroxycortisol \u2014 is there clinical utility of these steroids?. Eur. J. Endocrinol. 178, 517\u2013563 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"41005_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","volume":"411","author":"S Monticone","year":"2015","unstructured":"Monticone, S. et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol. Cell. Endocrinol. 411, 146\u2013154 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"41005_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi, G. P. et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 63, 151\u2013160 (2014).","journal-title":"Hypertension"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41005-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:03:52Z","timestamp":1774530232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41005"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41005-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8268064\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10071"}}